Page last updated: 2024-10-27

fluorouracil and Abdominal Obesity

fluorouracil has been researched along with Abdominal Obesity in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"Patients with colon cancer who prematurely discontinue postoperative chemotherapy may have an increased risk of disease recurrence and death."1.72The association of abdominal adiposity with premature discontinuation of postoperative chemotherapy in colon cancer. ( Brown, JC; Caan, BJ; Cespedes Feliciano, EM; Cheng, E; Meyerhardt, JA, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brown, JC1
Meyerhardt, JA1
Cespedes Feliciano, EM1
Cheng, E1
Caan, BJ1

Other Studies

1 other study available for fluorouracil and Abdominal Obesity

ArticleYear
The association of abdominal adiposity with premature discontinuation of postoperative chemotherapy in colon cancer.
    Clinical nutrition (Edinburgh, Scotland), 2022, Volume: 41, Issue:7

    Topics: Adiposity; Cohort Studies; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Neoplasm Recurrence,

2022